The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mutational profiling of appendiceal tumors from diagnostic specimens and circulating tumor DNA.
 
Patrick Wagner
No Relationships to Disclose
 
Sefali Patel
No Relationships to Disclose
 
Christopher Sherry
No Relationships to Disclose
 
Louis Gil
No Relationships to Disclose
 
Patti Petrosko
No Relationships to Disclose
 
Phillip Gallo
No Relationships to Disclose
 
Hyun Young Park
No Relationships to Disclose
 
Neda Dadgar
No Relationships to Disclose
 
Ashten Omstead
No Relationships to Disclose
 
Erin Grayhack
No Relationships to Disclose
 
Ajay Goel
Consulting or Advisory Role - Cellomics International Limited; Marker Health; Pharus Diagnostics
Patents, Royalties, Other Intellectual Property - I currently have several patents issued or pending, and a couple of them have been licensed to Pharus and Cellomics. However, none of these are at this point resulting in any royalty payments.
 
Ali Zaidi
Stock and Other Ownership Interests - Previse; TG Therapeutics
Consulting or Advisory Role - BillionToOne; Delfi Diagnostics; Gilead Sciences; PrognomIQ
Research Funding - BillionToOne; Delfi Diagnostics; Exai Bio; Genece Health; Myriad Genetics; PrognomIQ; Roche/Genentech; Tempus
 
William LaFramboise
Stock and Other Ownership Interests - Prevencio
Patents, Royalties, Other Intellectual Property - Patents associated with the technology utilized by Prevencio.
 
David Bartlett
No Relationships to Disclose